Lipopolysaccharide regulation of toll-like receptor-4 and matrix metalloprotease-9 in human primary corneal fibroblasts

脂多糖对人类原发性角膜成纤维细胞中 Toll 样受体 4 和基质金属蛋白酶 9 的调节

阅读:5
作者:Yuk Wong, Claire Sethu, Fethi Louafi, Parwez Hossain

Conclusions

TLR4 activation with LPS increases TLR4, MMP-9, and cytokine expression in CFs cultured from patients with microbial keratitis. Overexpression of these products may provide a local mechanism to eradicate bacterial infection but may also aid corneal ulceration and perforation.

Methods

Human primary CFs from patients with severe corneal ulceration were cultured in conjunction with healthy control CFs and treated with LPS derived from Pseudomonas aeruginosa.

Purpose

Toll-like receptor 4 (TLR4) is a key component of the innate immune response related to microbial keratitis (MK). Pathways and downstream effectors relating to TLR signaling remain unknown in human bacterial MK. To this effect, by activating the TLR4 signaling cascade with lipopolysaccharide (LPS), the authors investigated whether TLR4, matrix metalloproteases (MMP)-2, MMP-9, and cytokine expression in diseased human primary corneal fibroblasts (CFs) were altered.

Results

TLR4, MMP-2, and MMP-9 were constitutively expressed in both ulcerated and control CFs. Diseased CFs showed greater responsiveness to LPS stimulation. TLR4 and MMP-9 expression was dose-dependently increased by LPS. MMP-2 expression was not affected by LPS. Analysis on cytokine expression revealed that IL-2, IL-8, IL-10, IL-12p70, GM-CSF, IFNγ, and TNFα expression increased after LPS treatment but only in diseased cells. Conclusions: TLR4 activation with LPS increases TLR4, MMP-9, and cytokine expression in CFs cultured from patients with microbial keratitis. Overexpression of these products may provide a local mechanism to eradicate bacterial infection but may also aid corneal ulceration and perforation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。